DaVita HealthCare Partners Inc (DVA)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 16,893,600 16,928,700 16,958,800 16,727,800 16,928,300 16,961,800 17,100,600 17,087,000 17,121,500 17,633,900 17,810,300 17,647,300 16,988,500 17,046,700 19,305,100 17,596,300 17,311,400 17,451,800 19,931,000 22,605,900
Total stockholders’ equity US$ in thousands 1,056,100 1,199,200 1,017,440 825,470 712,326 532,672 604,784 843,771 755,508 1,149,440 1,277,780 1,248,110 1,383,570 1,574,760 2,153,920 1,947,850 2,133,410 2,318,580 4,049,300 3,875,350
Financial leverage ratio 16.00 14.12 16.67 20.26 23.76 31.84 28.28 20.25 22.66 15.34 13.94 14.14 12.28 10.82 8.96 9.03 8.11 7.53 4.92 5.83

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $16,893,600K ÷ $1,056,100K
= 16.00

The financial leverage ratio of DaVita Inc has been fluctuating over the past eight quarters.

In Q4 2022, the financial leverage ratio was at its highest at 31.84, indicating a high level of financial leverage and potentially higher financial risk for the company. However, the ratio showed a significant decrease in subsequent quarters, reaching its lowest point in Q3 2023 at 14.12.

The ratio then increased in Q4 2023 to 16.00, but still remained below the levels seen in the earlier periods. Overall, the trend suggests that DaVita Inc has been actively managing its financial leverage, aiming to reduce the reliance on debt to finance its operations.

It is important to monitor this ratio in the future to assess the company's ability to meet its financial obligations and to evaluate the effectiveness of its leverage management strategies.


Peer comparison

Dec 31, 2023

Company name
Symbol
Financial leverage ratio
DaVita HealthCare Partners Inc
DVA
16.00
Progyny Inc
PGNY
1.37
Sotera Health Co
SHC
7.05